The EANO Youngsters Initiative
The recently started EANO Youngsters Initiative aims to provide a platform for networking, interaction and collaboration between young scientists with a special interest in Neuro-Oncology. Therefore, the EANO Youngsters committee was formed to organize activities specially focusing on young scientists within the EANO. Here, the EANO Youngsters aim to represent the diversity of EANO with a lot of different specialties involved in Neuro-Oncology as well as to represent the different scientific interest from a clinical as well as a translational and basic science viewpoint. In the following we want to introduce the initiative, ourselves as well as to provide a broad overview on the planned activities.
The EANO Youngsters committee says “Hello”
The EANO Youngsters committee is in charge to organize the activities of the newly formed EANO Youngsters Initiative. We are all young scientists from different fields of interest and different European countries.
Anna Berghoff is in medical oncology training at the Medical University of Vienna, Austria. She finished the PhD program “Clinical Neuroscience” in 2014 with the main focus on clinical and pathological prognostic factors in brain metastases.
Carina Thomé is a biologist currently holding a PhD position at the German Cancer Research Center (Heidelberg, Germany) and has her research focus on the interaction of glioma cells with the inflammatory microenvironment.
Asgeir Jakola is a neurosurgeon and assoc. professor at the Sahlgrenska University Hospital, Gothenburg, Sweden. His main clinical and certainly also research interest is quality of life in glioma patients after neurosurgical resection.
Alessia Pellerino completed her Neurology residency in 2016 and joined a PhD position in Neuroscience at the Department of Neuroscience of the University of Turin afterwards. She has a particular interest in clinical trials design in Neuro-Oncology with a focus on new therapeutic drugs.
Tobias Weiss is just about to finish his training in neurology at the University of Zurich. Further, he joined the MD-PhD program in Immunology in 2015 to deepen his research in immunotherapeutic approaches against malignant brain tumors.